An at-home diagnostic test for screening colorectal cancer through fecal occult blood detection. Provides laboratory accuracy results in minutes from home with privacy and convenience.
Manufactured by
Biomerica, Inc.
United States
Biomerica, Inc. is a global biomedical company that develops, manufactures and markets advanced diagnostic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for the early detection of medical conditions and diseases. The company's products are designed to enhance health and well-being, while reducing total healthcare costs. Biomerica primarily focuses on products for gastrointestinal disease, diabetes and esoteric testing.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Camtech Diagnostics Pte Ltd
Singapore · 1 relevant product
HymonBio Co., Ltd.
China · 1 relevant product
Chongqing BIOSTEC Biotechnology Co., Ltd
China · 2 relevant products
62 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 101 closest product alternatives
Camtech Diagnostics Pte Ltd · Singapore
Self-sampling colon cancer screening test designed for point-of-care diagnostics. This non-invasive testing solution enables early detection of colorectal cancer through convenient at-home sample collection, supporting mass screening programs and clinical diagnostic workflows.
HymonBio Co., Ltd. · China
HAEMOCERT™ is an in vitro diagnostic test for colorectal cancer screening that detects hemoglobin in stool samples. The test aids in identifying patients at risk of colorectal malignancy through non-invasive screening, supporting early detection and clinical decision-making in gastroenterology and primary care settings.
Chongqing BIOSTEC Biotechnology Co., Ltd · China
Non-invasive screening test for detecting occult blood in stool samples for colorectal cancer detection. Enables early identification of gastrointestinal bleeding and potential malignancy risk.
98 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products